Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Food Resource Equity and Sustainability for Health
Conditions:   BMI;   Blood Pressure
Intervention:   Behavioral: healthy eating and gardening
Sponsor:   University of Oklahoma
Not yet recruiting - verified August 2017

Mon, 14 Aug 2017 12:00:00 EDT


Pediatrics Owning Performance Study
Condition:   Diabetes Mellitus, Type 1
Intervention:   Device: Pops! One personalized mobile platform
Sponsors:   Children's Hospitals and Clinics of Minnesota;   Pops! Diabetes Care
Recruiting - verified August 2017

Mon, 14 Aug 2017 12:00:00 EDT


Exercise Using Chinese Yoga Improving Insomnia
Condition:   Exercise Promotion
Intervention:   Behavioral: Yoga
Sponsor:   Taichung Veterans General Hospital
Recruiting - verified August 2017

Sun, 13 Aug 2017 12:00:00 EDT


Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Canagliflozin;   Drug: Empagliflozin;   Drug: Dapagliflozin;   Drug: Dipeptidyl Peptidase-4 Inhibitor (DPP-4);   Drug: Glucagon-Like Peptide-1 Agonist (GLP-1);   Drug: Thiazolidinedione (TZD);   Drug: Sulfonylureas;   Drug: Insulin
Sponsor:   Janssen Research & Development, LLC
Active, not recruiting - verified August 2017

Fri, 11 Aug 2017 12:00:00 EDT


Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection
Condition:   Hepatitis B
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation - verified May 10, 2017

Fri, 11 Aug 2017 12:00:00 EDT


Analysis of the Effects of LED Phototherapy and Electrical Stimulation in the Healing of Diabetic Ulcers
Conditions:   Ulcer;   Diabetes Mellitus
Interventions:   Device: Light emitting diodes (LED);   Device: Fixed diphasic current
Sponsor:   University of Sao Paulo
Not yet recruiting - verified August 2017

Thu, 10 Aug 2017 12:00:00 EDT


E-Cigarette Inner City RCT
Conditions:   Tobacco Dependence;   COPD Asthma;   Mental Illness;   Substance Use
Intervention:   Device: Improved Quality of Life of low-income Canadians that smoke tobacco and other substances
Sponsor:   Ottawa Hospital Research Institute
Not yet recruiting - verified August 2017

Thu, 10 Aug 2017 12:00:00 EDT


Non-Myeloablative Conditioning Regimen With Haploidentical T-Cell-Depleted Peripheral Blood Transplant for Patients With Severe Sickle Cell Disease
Conditions:   Sickle Cell Disease;   Sickle Cell Disorder;   Hemoglobinopathies;   Thalassemia;   Anemia, Sickle Cell
Interventions:   Drug: Cyclophosphamide;   Drug: Pentostatin;   Drug: Rabbit anti-thymocyte globulin;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Biological: CD4+ T-cell-depleted Haploidentical Hematopoietic Transplant
Sponsor:   City of Hope Medical Center
Not yet recruiting - verified August 2017

Thu, 10 Aug 2017 12:00:00 EDT


ConnectedHeartHealth - Heart Failure Readmission Intervention
Conditions:   Diabetes Mellitus;   Coronary Artery Disease;   Heart Failure
Intervention:   Behavioral: Ambio Health Remote Monitoring
Sponsors:   LifeBridge Health;   American Heart Association (AHA)
Recruiting - verified August 2017

Wed, 09 Aug 2017 12:00:00 EDT


Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
Conditions:   Type 2 Diabetes Mellitus;   Carotid Atherosclerosis
Interventions:   Drug: Cilostazol;   Drug: Aspirin
Sponsor:   Seoul National University Bundang Hospital
Recruiting - verified August 2017

Wed, 09 Aug 2017 12:00:00 EDT


PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer
Condition:   Diabetic Foot Ulcer
Intervention:   Biological: PRG combined with BMMSCs transplantation
Sponsor:   Third Military Medical University
Recruiting - verified August 2017

Wed, 09 Aug 2017 12:00:00 EDT


The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Choline alfoscerate;   Drug: Placebo
Sponsor:   Seoul National University Bundang Hospital
Recruiting - verified August 2017

Wed, 09 Aug 2017 12:00:00 EDT


Efficacy of Platelet Rich Plasma Injection in Diabetic Neuropathy
Condition:   Diabetic Peripheral Neuropathy
Interventions:   Drug: PRP injection;   Other: traditional medical treatment
Sponsor:   Assiut University
Recruiting - verified August 2017

Tue, 08 Aug 2017 12:00:00 EDT


Evaluating the Implementation of the Diabetes Prevention Program in an Integrated Health System
Condition:   Diabetes
Intervention:   Behavioral: Medicare DPP
Sponsor:   Kaiser Permanente
Active, not recruiting - verified August 2017

Tue, 08 Aug 2017 12:00:00 EDT


Project Powerfood: Promoting Food Security, Equity, and Health
Conditions:   Diabetes;   Obesity
Interventions:   Other: Autumn Group;   Other: Spring Group
Sponsors:   Icahn School of Medicine at Mount Sinai;   New York Common Pantry;   Corbin Hill Food Project;   Wholesome Wave
Recruiting - verified August 2017

Tue, 08 Aug 2017 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA warns of potential contamination in multiple brands of drugs, dietary supplements
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby Laboratories, Major Pharmaceuticals and Leader Brands, due to potential contamination with the bacteria Burkholderia cepacia (B. cepacia) and the risk for severe patient infection.

Fri, 11 Aug 2017 15:34:00 -0400


FDA to expand public education campaign to focus on prevention of youth e-cigarette use
Today, the U.S. Food and Drug Administration announced it would pursue a strategic, new public health education campaign aimed at discouraging the use of e-cigarettes and other electronic nicotine delivery systems (ENDS) by kids. The agency plans to expand its “The Real Cost” public education campaign to include messaging to teens about the dangers of using these products this fall while developing a full-scale campaign to launch in 2018. These efforts are part of the agency’s new comprehensive plan for tobacco and nicotine regulation, as well as ongoing efforts to educate youth about, and protect them from, the dangers associated with using all tobacco products. It is the first time the FDA will be utilizing public health education to specifically target youth use of e-cigarettes or other ENDS.

Tue, 08 Aug 2017 10:00:00 -0400


Federal judge enters consent decree against outsourcing facility Isomeric Pharmacy Solutions
U.S. District Judge Robert J. Shelby entered a consent decree of permanent injunction yesterday between the United States and Isomeric Pharmacy Solutions of Salt Lake City, Utah, two of the company’s co-owners, William O. Richardson and Rachael S. Cruz, and chief operating officer Jeffery D. Brown.

Fri, 04 Aug 2017 10:17:00 -0400


FDA approves Mavyret for Hepatitis C
The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis. Mavyret is also approved for adult patients with HCV genotype 1 infection who have been previously treated with a regimen either containing an NS5A inhibitor or an NS3/4A protease inhibitor but not both.

Thu, 03 Aug 2017 15:06:00 -0400


FDA approves first treatment for certain types of poor-prognosis acute myeloid leukemia
The U.S. Food and Drug Administration today approved Vyxeos for the treatment of adults with two types of acute myeloid leukemia (AML): newly diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). Vyxeos is a fixed-combination of chemotherapy drugs daunorubicin and cytarabine.

Thu, 03 Aug 2017 09:09:00 -0400


FDA approves treatment for chronic graft versus host disease
The U.S. Food and Drug Administration today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) after failure of one or more treatments. This is the first FDA-approved therapy for the treatment of cGVHD.

Wed, 02 Aug 2017 11:30:00 -0400


FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia
The U.S. Food and Drug Administration today approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation. The drug is approved for use with a companion diagnostic, the RealTime IDH2 Assay, which is used to detect specific mutations in the IDH2 gene in patients with AML.

Tue, 01 Aug 2017 11:10:00 -0400


FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death
The U.S. Food and Drug Administration today announced a new comprehensive plan for tobacco and nicotine regulation that will serve as a multi-year roadmap to better protect kids and significantly reduce tobacco-related disease and death. The approach places nicotine, and the issue of addiction, at the center of the agency’s tobacco regulation efforts. The goal is to ensure that the FDA has the proper scientific and regulatory foundation to efficiently and effectively implement the Family Smoking Prevention and Tobacco Control Act. To make certain that the FDA is striking an appropriate balance between regulation and encouraging development of innovative tobacco products that may be less dangerous than cigarettes, the agency is also providing targeted relief on some timelines described in the May 2016 final rule that extended the FDA’s authority to additional tobacco products. The agency will also seek input on critical public health issues such as the role of flavors in tobacco products.

Fri, 28 Jul 2017 09:55:00 -0400


FDA clears first neonatal magnetic resonance imaging device
Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging (MRI) device specifically for neonatal brain and head imaging in neonatal intensive care units (NICU).

Thu, 20 Jul 2017 13:44:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on the Funding Awards to States for FDA Food Safety Modernization Act (FSMA) Produce Safety Implementation
More than 3,000 Americans are estimated to die each year from foodborne illnesses and many more are hospitalized and sickened. Yet most of these illnesses and deaths are preventable. While the U.S. has one of the safest food supplies in the world, Congress entrusted the FDA with new authorities and resources – as part of the FDA Food Safety Modernization Act (FSMA) – to update and strengthen the FDA’s risk-based approach to the oversight of food safety.

Wed, 19 Jul 2017 09:46:00 -0400
Diabetes news from the American Diabetes Association

Latest Top (5) News